FDA Investigator Ying Zhang
Ying Zhang has conducted inspections on 4 sites in 3 countries as of 16 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
16 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
India,
United States of America,
Puerto Rico
FDA Investigators that have inspected at least one site in common with Ying Zhang:
Amy L Singer,
Ankur C Patel,
Anna M Brannen,
Ariel Cruz Figueroa,
Arlene M Badillo,
Barbara Jwilimczyk Macri,
Bethany L Subel,
Byeongtaek Oh,
Christina Capacci Daniel, PhD,
Christopher T Middendorf,
Cynthia T Cain,
Daniel L Obrzut,
Edwin Martinez,
Elizabeth Ll Edwards,
Frederick F Razzaghi,
German Rivera,
Jon P Antoniou,
Jorge L Guadalupe,
Jose A Lopez,
José E Meléndez,
Joshua P Wireman,
Kenneth E Felkley,
Krishna Ghosh, PhD,
Lareese K Thomas,
Lauren N Howard,
Lauren N Smith,
Laurimer Kuilan Torres,
Libia M Lugo,
Lindsey M Schwierjohann,
Logan T Williams,
Madushini Dharmasena, PhD,
Marea K Harmon,
Margaret M Sands,
Marian E Ramirez,
Marianela Aponte Cruz,
Marianne Allen,
Mark E Parmon,
Michael P Sheehan,
Myriam M Sosa,
Nicholas L Paulin,
Noreen Muñiz,
Paranthaman Senthamaraikannan,
Paul L Bellamy,
Ramon A Hernandez,
Rapti D Madurawe,
Raquel Gonzalez Rivera,
Rebecca Parrilla,
Rose Xu,
Russell J Glapion,
Steven P Eastham,
Tamil Arasu, PhD,
Tarun D Mehta,
Thomas J Arista,
Tracey L Harris,
Unnee Ranjan,
Vilmary Negron Rodriguez,
Wen Ning Chan (Sally),
Yifan Wang
Ying Zhang's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2015 | FDA 483 | CMIC CMO USA CORP - Form 483, 2015-02-13 |
February, 2015 | FDA 483 Response | CMIC CMO USA CORP - Form 483R, 2015-03-06 |
February, 2019 | FDA 483 | Patheon Pharmaceuticals Inc. - Form 483, 2019-02-15 |
February, 2019 | EIR | Patheon Pharmaceuticals Inc. - EIR, 2019-02-15 |
July, 2017 | FDA 483 | Lilly del Caribe, Inc. - Form 483, 2017-07-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more